Announcements Trials
Browse Landscape

Phase

Phase 1 7Phase 3 1Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Leukemia, Myeloid, Chronic-Phase 4Leukemia, Myelogenous, Chronic, BCR-ABL Positive 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Leukemia 3Prostatic Neoplasms 1Philadelphia Chromosome 1Leukemia, Myeloid, Acute 1Leukemia, Myeloid, Accelerated Phase 1Burkitt Lymphoma 1Bronchiolitis Obliterans Syndrome 1

Interventions

Peripheral Blood Stem Cell Transplantation 3Methotrexate 3Early Intervention, Educational 3Cyclosporine 3Cyclophosphamide 3liposomal amphotericin B 2Therapeutics 2Radiotherapy 2Psychiatric Rehabilitation 2Vancomycin 1Valacyclovir 1Tazobactam 1Ribavirin 1Piperacillin, Tazobactam Drug Combination 1Piperacillin 1Pharmacogenomic Testing 1Palivizumab 1Ondansetron 1Mycophenolic Acid 1Moxifloxacin 1Morphine 1Methylprednisolone 1Levofloxacin 1Ketamine 1Itraconazole 1Hypericum extract LI 160 1Fluconazole 1Filgrastim 1Fentanyl 1Dextromethorphan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Leukemia, Myeloid, Accelerated Phase × Dasatinib × Clear all
NCT00123487 2014-11-03

Advanced Chronic Myelogenous Leukemia (CML) - Follow On: Study of BMS-354825 in Subjects With CML

Bristol-Myers Squibb

Phase 3 Completed
638 enrolled 28 charts
LymphoidOther hematologic neoplasm

Leukemia, Myeloid, Accelerated Phase, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡